If you are considering using retatrutide or any other unlicensed peptide for weight management or metabolic health, the most important step you can take is to consult a qualified healthcare professional before proceeding
It rose gradually during the dose-escalation phase, peaked around week 24, and then declined at weeks 36 and 48 even though participants continued taking the same dose
Understanding these mechanisms helps clinicians select the most appropriate GLP-1 agonist for individual patients and set realistic expectations regarding tolerability
At present, there is a balance payers must achieve across a variety of influencing factors on whether to cover GLP-1s (see Figure 1)
I gave them a call, and was again impressed, this time with the quality of our interactions
Your healthcare provider or a registered dietitian can help determine the right targets for your body and your pace of weight loss